// App-Quantinova.ai

204 : Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC).

Researchers

Presenter

  • Gurveen Kaur

Principal Investigators

  • Beerinder Singh

  • Himisha Beltran

  • Naveed Hassan Akhtar

  • David M. Nanus

  • Scott T. Tagawa

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Department of Pathology & Laboratory Medicine, Englader Institute for Precision Medicine, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Neuroendocrine tumors

  • Brain metastasis

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved